Perinatal neuroprotection

Current Anaesthesia and Critical Care

Volumn 18, Issue 4, 2007, Pages 215-224

  Sanders, R D ^a,b   Manning, H J ^c   Ma, D ^b   Maze, M ^a,b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^c BASINGSTOKE AND NORTH HAMPSHIRE HOSPITAL   (United Kingdom)

Author keywords

Glutamate; Hypothermia; Hypoxic encephalopathy; Ischaemic encephalopathy; NMDA receptors

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; ANESTHETIC AGENT; ANTIOXIDANT; BARBITURIC ACID DERIVATIVE; CALCIUM CHANNEL BLOCKING AGENT; CLONIDINE; DESFLURANE; DEXAMETHASONE; DEXMEDETOMIDINE; ERYTHROPOIETIN; FREE RADICAL; INHALATION ANESTHETIC AGENT; KETAMINE; MAGNESIUM SULFATE; MANNITOL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NITROUS OXIDE; PENTOBARBITAL; SEDATIVE AGENT; THIOPENTAL; XANTHINE OXIDASE INHIBITOR; XENON;

ARTICLE; BRAIN DISEASE; BRAIN HYPOXIA; BRAIN INJURY; BRAIN ISCHEMIA; CENTRAL NERVOUS SYSTEM; CLINICAL TRIAL; DIAGNOSTIC PROCEDURE; DISEASE MODEL; DRUG EFFICACY; DRUG POTENTIATION; ENERGY; HUMAN; HYPOTENSION; INDUCED HYPOTHERMIA; INFLAMMATION; NERVE CELL LESION; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PATHOGENESIS; PERINATAL ASPHYXIA; PERINATAL PERIOD; PRIORITY JOURNAL; RESPIRATION DEPRESSION; RISK FACTOR; SIDE EFFECT; TOCOLYSIS;

EID: 35548958186     PISSN: 09537112     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cacc.2007.03.012     Document Type: Article

References (63)

1. Whitelaw A., and Thoresen M. Clinical trials of treatments after perinatal asphyxia. Curr Opin Pediatr 14 6 (2002) 664-668
2. Nakajima W., Ishida A., Lange M.S., Gabrielson K.L., Wilson M.A., Martin L.J., et al. Apoptosis has a prolonged role in the neurodegeneration after hypoxic ischemia in the newborn rat. J Neurosci 20 21 (2000) 7994-8004
3. Gluckman P.D., Wyatt J.S., Azzopardi D., Ballard R., Edwards A.D., Ferriero D.M., et al. Selective head cooling with mild systemic hypothermia after neonatal encephalopathy: multicentre randomised trial. Lancet 365 9460 (2005) 663-670
4. Shankaran S., Laptook A.R., Ehrenkranz R.A., Tyson J.E., McDonald S.A., Donovan E.F., et al. Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy. N Engl J Med 353 15 (2005) 1574-1584
5. Badawi N., Kurinczuk J.J., Keogh J.M., Alessandri L.M., O'Sullivan F., Burton P.R., et al. Antepartum risk factors for newborn encephalopathy: the Western Australian case-control study. BMJ 317 7172 (1998) 1549-1553
6. Nelson K.B., and Ellenberg J.H. Antecedents of cerebral palsy. Multivariate analysis of risk. N Engl J Med 315 2 (1986) 81-86
7. Graham E.M., Petersen S.M., Christo D.K., and Fox H.E. Intrapartum electronic fetal heart rate monitoring and the prevention of perinatal brain injury. Obstet Gynecol 108 3 Pt 1 (2006) 656-666
8. American Academy of Pediatrics. American College of Obstetricians and Gynecologists. Neonatal encephalopathy and cerebral palsy: defining the pathogenesis and pathophysiology (2003), Elk Grove Village (IL): AAP, Washington, DC
9. Kubli F.W., Hon E.H., Khazin A.F., and Takemura H. Observations on heart rate and pH in the human fetus during labor. Am J Obstet Gynecol 104 8 (1969) 1190-1206
10. Nelson K.B., Dambrosia J.M., Ting T.Y., and Grether J.K. Uncertain value of electronic fetal monitoring in predicting cerebral palsy. N Engl J Med 334 10 (1996) 613-618
11. Low J.A., Victory R., and Derrick E.J. Predictive value of electronic fetal monitoring for intrapartum fetal asphyxia with metabolic acidosis. Obstet Gynecol 93 2 (1999) 285-291
12. Alfirevic Z, Devane D, Gyte GM. Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour. Cochrane Database Syst Rev 2006;3:CD006066.
13. Cowan F., Rutherford M., Groenendaal F., Eken P., Mercuri E., Bydder G.M., et al. Origin and timing of brain lesions in term infants with neonatal encephalopathy. Lancet 361 9359 (2003) 736-742
14. Allen R.M., Bowling F.G., and Oats J.J. Determining the fetal scalp lactate level that indicates the need for intervention in labour. Aust N Z J Obstet Gynaecol 44 6 (2004) 549-552
15. Kruger K., Hallberg B., Blennow M., Kublickas M., and Westgren M. Predictive value of fetal scalp blood lactate concentration and pH as markers of neurologic disability. Am J Obstet Gynecol 181 5 Pt 1 (1999) 1072-1078
16. ACOG Committee on Obstetric Practice. ACOG Committee Opinion No. 348, November 2006: umbilical cord blood gas and acid-base analysis. Obstet Gynecol 108 5 (2006) 1319-1322
17. Westgate J., Harris M., Curnow J.S., and Greene K.R. Plymouth randomized trial of cardiotocogram only versus ST waveform plus cardiotocogram for intrapartum monitoring in 2400 cases. Am J Obstet Gynecol 169 5 (1993) 1151-1160
18. Siristatidis C., Salamalekis E., Kassanos D., Loghis C., and Creatsas G. Evaluation of fetal intrapartum hypoxia by middle cerebral and umbilical artery Doppler velocimetry with simultaneous cardiotocography and pulse oximetry. Arch Gynecol Obstet 270 4 (2004) 265-270
19. Johnston M.V. Excitotoxicity in perinatal brain injury. Brain Pathol 15 3 (2005) 234-240
20. Olney J.W. Excitotoxicity, apoptosis and neuropsychiatric disorders. Curr Opin Pharmacol 3 1 (2003) 101-109
21. Edwards A.D., and Tan S. Perinatal infections, prematurity and brain injury. Curr Opin Pediatr 18 2 (2006) 119-124
22. Eklind S., Mallard C., Arvidsson P., and Hagberg H. Lipopolysaccharide induces both a primary and a secondary phase of sensitization in the developing rat brain. Pediatr Res 58 1 (2005) 112-116
23. Yoon B.H., Romero R., Yang S.H., Jun J.K., Kim I.O., Choi J.H., and Syn H.C. Interleukin-6 concentrations in umbilical cord plasma are elevated in neonates with white matter lesions associated with periventricular leukomalacia. Am J Obstet Gynecol 174 5 (1996) 1433-1440
24. Loddick S.A., Turnbull A.V., and Rothwell N.J. Cerebral interleukin-6 is neuroprotective during permanent focal cerebral ischemia in the rat. J Cereb Blood Flow Metab 18 2 (1998) 176-179
25. Roth S.C., Baudin J., Cady E., Johal K., Townsend J.P., Wyatt J.S., et al. Relation of deranged neonatal cerebral oxidative metabolism with neurodevelopmental outcome and head circumference at 4 years. Dev Med Child Neurol 39 11 (1997) 718-725
26. Robertson N.J., Cowan F.M., Cox I.J., and Edwards A.D. Brain alkaline intracellular pH after neonatal encephalopathy. Ann Neurol 52 6 (2002) 732-742
27. Rutherford M.A., Azzopardi D., Whitelaw A., Cowan F., Renowden S., Edwards A.D., et al. Mild hypothermia and the distribution of cerebral lesions in neonates with hypoxic-ischemic encephalopathy. Pediatrics 116 4 (2005) 1001-1006
28. Busto R., Globus M.Y., Dietrich W.D., Martinez E., Valdes I., and Ginsberg M.D. Effect of mild hypothermia on ischemia-induced release of neurotransmitters and free fatty acids in rat brain. Stroke 20 7 (1989) 904-910
29. Xu L., Yenari M.A., Steinberg G.K., and Giffard R.G. Mild hypothermia reduces apoptosis of mouse neurons in vitro early in the cascade. J Cereb Blood Flow Metab 22 1 (2002) 21-28
30. Zhao H., Shimohata T., Wang J.Q., Sun G., Schaal D.W., Sapolsky R.M., et al. Akt contributes to neuroprotection by hypothermia against cerebral ischemia in rats. J Neurosci 25 42 (2005) 9794-9806
31. Thoresen M., Satas S., Loberg E.M., Whitelaw A., Acolet D., Lindgren C., et al. Twenty-four hours of mild hypothermia in unsedated newborn pigs starting after a severe global hypoxic-ischemic insult is not neuroprotective. Pediatr Res 50 3 (2001) 405-411
32. Westermaier T., Zausinger S., Baethmann A., Steiger H.J., and Schmid-Elsaesser R. No additional neuroprotection provided by barbiturate-induced burst suppression under mild hypothermic conditions in rats subjected to reversible focal ischemia. J Neurosurg 93 5 (2000) 835-844
33. Levene M.I., Evans D.H., Forde A., and Archer L.N. Value of intracranial pressure monitoring of asphyxiated newborn infants. Dev Med Child Neurol 29 3 (1987) 311-319
34. Mujsce D.J., Towfighi J., Stern D., and Vannucci R.C. Mannitol therapy in perinatal hypoxic-ischemic brain damage in rats. Stroke 21 8 (1990) 1210-1214
35. Hall R.T., Hall F.K., and Daily D.K. High-dose phenobarbital therapy in term newborn infants with severe perinatal asphyxia: a randomized, prospective study with three-year follow-up. J Pediatr 132 2 (1998) 345-348
36. Goldberg R.N., Moscoso P., Bauer C.R., Bloom F.L., Curless R.G., Burke B., et al. Use of barbiturate therapy in severe perinatal asphyxia: a randomized controlled trial. J Pediatr 109 5 (1986) 851-856
37. Ruth V., Virkola K., Paetau R., and Raivio K.O. Early high-dose phenobarbital treatment for prevention of hypoxic-ischemic brain damage in very low birth weight infants. J Pediatr 112 1 (1988) 81-86
38. Robinson S., Li Q., Dechant A., and Cohen M.L. Neonatal loss of gamma-aminobutyric acid pathway expression after human perinatal brain injury. J Neurosurg 104 6 Suppl (2006) 396-408
39. Kurth C.D., Priestley M., Watzman H.M., McCann J., and Golden J. Desflurane confers neurologic protection for deep hypothermic circulatory arrest in newborn pigs. Anesthesiology 95 4 (2001) 959-964
40. Loepke A.W., Priestley M.A., Schultz S.E., McCann J., Golden J., and Kurth C.D. Desflurane improves neurologic outcome after low-flow cardiopulmonary bypass in newborn pigs. Anesthesiology 97 6 (2002) 1521-1527
41. Jevtovic-Todorovic V., Hartman R.E., Izumi Y., Benshoff N.D., Dikranian K., Zorumski C.F., et al. Early exposure to common anesthetic agents causes widespread neurodegeneration in the developing rat brain and persistent learning deficits. J Neurosci 23 3 (2003) 876-882
42. Laudenbach V., Mantz J., Lagercrantz H., Desmonts J.M., Evrard P., and Gressens P. Effects of alpha(2)-adrenoceptor agonists on perinatal excitotoxic brain injury: comparison of clonidine and dexmedetomidine. Anesthesiology 96 1 (2002) 134-141
43. Ma D., Hossain M., Rajakumaraswamy N., Arshad M., Sanders R.D., Franks N.P., and Maze M. Dexmedetomidine produces its neuroprotective effect via the alpha 2A-adrenoceptor subtype. Eur J Pharmacol 502 1-2 (2004) 87-97
44. Rajakumaraswamy N., Ma D., Hossain M., Sanders R.D., Franks N.P., and Maze M. Neuroprotective interaction produced by xenon and dexmedetomidine on in vitro and in vivo neuronal injury models. Neurosci Lett 409 2 (2006) 128-133
45. Sanders R.D., Ma D., and Maze M. Anaesthesia induced neuroprotection. Best Pract Res Clin Anaesthesiol 19 3 (2005) 461-474
46. Guerguerian A.M., Brambrink A.M., Traystman R.J., Huganir R.L., and Martin L.J. Altered expression and phosphorylation of N-methyl-D-aspartate receptors in piglet striatum after hypoxia-ischemia. Brain Res Mol Brain Res 104 1 (2002) 66-80
47. Nelson K.B., and Grether J.K. Can magnesium sulfate reduce the risk of cerebral palsy in very low birthweight infants?. Pediatrics 95 2 (1995) 263-269
48. Crowther C.A., Hiller J.E., Doyle L.W., Haslam R.R., and Australasian Collaborative Trial of Magnesium Sulphate (ACTOMg SO4) Collaborative Group. Effect of magnesium sulfate given for neuroprotection before preterm birth: a randomized controlled trial. JAMA 290 20 (2003) 2669-2676
49. Greenwood K., Cox P., Mehmet H., Penrice J., Amess P.N., et al. Magnesium sulfate treatment after transient hypoxia-ischemia in the newborn piglet does not protect against cerebral damage. Pediatr Res 48 3 (2000) 346-350
50. Young C., Jevtovic-Todorovic V., Qin Y.Q., Tenkova T., Wang H., Labruyere J., et al. Potential of ketamine and midazolam, individually or in combination, to induce apoptotic neurodegeneration in the infant mouse brain. Br J Pharmacol 146 2 (2005) 189-197
51. Ma D, Williamson P, Januszewski A, Nogaro MC, et al. Xenon mitigates isoflurane-induced neurodegeneration in the developing rodent brain. Anesthesiology in press.
52. Sanders R.D., Ma D., and Maze M. Xenon: elemental anaesthesia in clinical practice. Br Med Bull 71 (2005) 115-135
53. Ma D., Hossain M., Chow A., Arshad M., Battson R.M., Sanders R.D., et al. Xenon and hypothermia combine to provide neuroprotection from neonatal asphyxia. Ann Neurol 58 2 (2005) 182-193
54. Martin J.L., Ma D., Hossain M., Xu J., Sanders R.D., Franks N.P., et al. Asynchronous administration of xenon and hypothermia significantly reduces brain infarction in the neonatal rat. Br J Anaesth 98 2 (2007) 236-240
55. Ruth V., Autti-Ramo I., Granstrom M.L., Korkman M., and Raivio K.O. Prediction of perinatal brain damage by cord plasma vasopressin, erythropoietin, and hypoxanthine values. J Pediatr 113 5 (1988) 880-885
56. Spandou E., Papadopoulou Z., Soubasi V., Karkavelas G., Simeonidou C., Pazaiti A., et al. Erythropoietin prevents long-term sensorimotor deficits and brain injury following neonatal hypoxia-ischemia in rats. Brain Res 1045 1-2 (2005) 22-30
57. Weber A., Dzietko M., Berns M., Felderhoff-Mueser U., Heinemann U., Maier R.F., et al. Neuronal damage after moderate hypoxia and erythropoietin. Neurobiol Dis 20 2 (2005) 594-600
58. Lim T, Ma D, To C, Maze M, Maxwell P. Xenon-Induced Hypoxia-inducible factor-1 alpha in preconditioning of neural and non-neural tissue. ASA abstract 2006; A1186.
59. Niijima S., Shortland D.B., Levene M.I., and Evans D.H. Transient hyperoxia and cerebral blood flow velocity in infants born prematurely and at full term. Arch Dis Child 63 10 Spec No (1988) 1126-1130
60. Kutzsche S., Ilves P., Kirkeby O.J., and Saugstad O.D. Hydrogen peroxide production in leukocytes during cerebral hypoxia and reoxygenation with 100% or 21% oxygen in newborn piglets. Pediatr Res 49 6 (2001) 834-842
61. Tan A., Schulze A., O'Donnell C.P., and Davis P.G. Air versus oxygen for resuscitation of infants at birth. Cochrane Database Syst Rev 2 (2005) CD002273
62. Peeters-Scholte C., Braun K., Koster J., Kops N., Blomgren K., Buonocore G., et al. Effects of allopurinol and deferoxamine on reperfusion injury of the brain in newborn piglets after neonatal hypoxia-ischemia. Pediatr Res 54 4 (2003) 516-522
63. Van Bel F., Shadid M., Moison R.M., Dorrepaal C.A., Fontijn J., Monteiro L., et al. Effect of allopurinol on postasphyxial free radical formation, cerebral hemodynamics, and electrical brain activity. Pediatrics 101 2 (1998) 185-193